CRISM Therapeutics (CRTX) Competitors GBX 10.21 +0.06 (+0.59%) As of 11:36 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock CRTX vs. BRES, ARCM, CMET, VAST, CLA, 80M, BMV, LND, GLR, and BZTShould you be buying CRISM Therapeutics stock or one of its competitors? The main competitors of CRISM Therapeutics include Blencowe Resources (BRES), Arc Minerals (ARCM), Capital Metals (CMET), Vast Resources (VAST), Celsius Resources (CLA), 80 Mile (80M), Bluebird Merchant Ventures (BMV), Landore Resources (LND), Galileo Resources (GLR), and Bezant Resources (BZT). These companies are all part of the "other industrial metals & mining" industry. CRISM Therapeutics vs. Its Competitors Blencowe Resources Arc Minerals Capital Metals Vast Resources Celsius Resources 80 Mile Bluebird Merchant Ventures Landore Resources Galileo Resources Bezant Resources Blencowe Resources (LON:BRES) and CRISM Therapeutics (LON:CRTX) are both small-cap basic materials companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation and media sentiment. Do insiders and institutionals hold more shares of BRES or CRTX? 0.5% of Blencowe Resources shares are owned by institutional investors. Comparatively, 0.3% of CRISM Therapeutics shares are owned by institutional investors. 4.2% of Blencowe Resources shares are owned by company insiders. Comparatively, 97.3% of CRISM Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more risk & volatility, BRES or CRTX? Blencowe Resources has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, CRISM Therapeutics has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500. Which has higher valuation and earnings, BRES or CRTX? CRISM Therapeutics has higher revenue and earnings than Blencowe Resources. Blencowe Resources is trading at a lower price-to-earnings ratio than CRISM Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBlencowe ResourcesN/AN/A-£1.28M-£0.00-2,000.00CRISM Therapeutics£25K163.20-£792.20K-£0.02-567.22 Does the media refer more to BRES or CRTX? In the previous week, CRISM Therapeutics had 1 more articles in the media than Blencowe Resources. MarketBeat recorded 1 mentions for CRISM Therapeutics and 0 mentions for Blencowe Resources. Blencowe Resources' average media sentiment score of 0.00 equaled CRISM Therapeutics'average media sentiment score. Company Overall Sentiment Blencowe Resources Neutral CRISM Therapeutics Neutral Is BRES or CRTX more profitable? CRISM Therapeutics' return on equity of -13.12% beat Blencowe Resources' return on equity.Company Net Margins Return on Equity Return on Assets Blencowe ResourcesN/A -16.02% -13.34% CRISM Therapeutics N/A -13.12%-26.77% SummaryCRISM Therapeutics beats Blencowe Resources on 6 of the 10 factors compared between the two stocks. Get CRISM Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRTX vs. The Competition Export to ExcelMetricCRISM TherapeuticsOther Industrial Metals & Mining IndustryMaterials SectorLON ExchangeMarket Cap£4.08M£964.95M£3.51B£2.56BDividend YieldN/A6.12%5.09%5.33%P/E Ratio-567.22150.05149.775,164.17Price / Sales163.2036,545.0014,082.8298,069.48Price / CashN/A24.7024.2227.93Price / Book0.247.686.407.36Net Income-£792.20K£71.98M£149.66M£5.89B7 Day Performance-0.87%3.67%3.08%0.71%1 Month Performance-3.41%12.42%10.13%45.99%1 Year PerformanceN/A56.11%39.57%181.68% CRISM Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRTXCRISM TherapeuticsN/AGBX 10.21+0.6%N/AN/A£4.08M£25K-567.224News CoverageGap UpHigh Trading VolumeBRESBlencowe ResourcesN/AGBX 4.75+2.2%N/A-7.7%£15.32MN/A-2,065.653Gap UpARCMArc MineralsN/AGBX 0.95-2.5%N/A-47.9%£14.12MN/A-634.0035Gap UpCMETCapital MetalsN/AGBX 3.20+3.2%N/A+93.9%£14.03MN/A-2,206.9022Gap DownVASTVast ResourcesN/AGBX 0.34-0.9%N/A+256.3%£13.21M£446K-28.03350Gap DownCLACelsius ResourcesN/AGBX 0.40+6.7%N/A-44.4%£12.09M£647.00-67.80N/AGap Up80M80 MileN/AGBX 0.29+4.8%N/AN/A£11.82MN/A-50.00N/AGap UpHigh Trading VolumeBMVBluebird Merchant VenturesN/AGBX 1.45+9.4%N/A+65.7%£11.66MN/A-439.399Gap UpLNDLandore ResourcesN/AGBX 3.10-1.6%N/A-13.6%£10.72MN/A-31,000.006Gap DownGLRGalileo ResourcesN/AGBX 1.02-0.8%N/A-9.6%£10.18MN/A678.001BZTBezant ResourcesN/AGBX 0.05+5.9%N/A+83.1%£8.74MN/A-540.005Gap Up Related Companies and Tools Related Companies Blencowe Resources Alternatives Arc Minerals Alternatives Capital Metals Alternatives Vast Resources Alternatives Celsius Resources Alternatives 80 Mile Alternatives Bluebird Merchant Ventures Alternatives Landore Resources Alternatives Galileo Resources Alternatives Bezant Resources Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CRTX) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | SponsoredA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISM Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISM Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
